Cheyne-Stokes Breathing: Clinical Significance and Management

Definition and Diagnostic Criteria

• Cheyne-Stokes breathing is characterized by episodes of at least 3 consecutive central apneas and/or central hypopneas separated by a crescendo-decrescendo change in breathing amplitude with a cycle length of at least 40 seconds, according to the American Academy of Sleep Medicine 1, 2
• For formal diagnosis, there must be 5 or more central apneas and/or central hypopneas per hour associated with this crescendo-decrescendo breathing pattern recorded over a minimum of 2 hours of monitoring, as recommended by the American Academy of Sleep Medicine 1, 3

Physiological Mechanisms

• The cycle length of Cheyne-Stokes breathing varies with the severity of heart failure, with patients having more severe left ventricular dysfunction typically having longer cycle lengths, as noted by the American Academy of Sleep Medicine 3, 4
• In heart failure patients, cycle lengths typically range from 45-90 seconds, compared to shorter cycle lengths in other forms of central sleep apnea, according to the American Academy of Sleep Medicine 4, 5

Clinical Significance

• A central apnea-hypopnea index (AHI) >30/hour in heart failure patients with Cheyne-Stokes breathing is a poor prognostic sign for survival, as indicated by the American Academy of Sleep Medicine 1, 3
• Longer duration of Cheyne-Stokes breathing is associated with higher mortality and elevated markers of poor cardiac function, such as NT-proBNP, as reported by the American Academy of Sleep Medicine 3, 6

Clinical Associations

• Cheyne-Stokes breathing is most commonly associated with heart failure but can also occur with other conditions, including neurological disorders, atrial fibrillation, pulmonary hypertension, and renal failure, as noted by the American Academy of Sleep Medicine 5
• Cheyne-Stokes breathing may reflect unrecognized congestive heart failure and is a risk factor for early mortality or the need for heart transplant in patients with known heart failure, according to the American Academy of Sleep Medicine 7, 2

Management Implications

• The American Academy of Sleep Medicine recommends focusing on optimizing guideline-based heart failure therapy as the primary intervention for Cheyne-Stokes breathing 8
• Cheyne-Stokes breathing often improves with effective treatment of the underlying heart failure, as reported by the American Academy of Sleep Medicine 8
• The duration of Cheyne-Stokes breathing or the number of events should be specified in sleep study reports, as recommended by the American Academy of Sleep Medicine 1, 6

Cheyne-Stokes Breathing Causes and Characteristics

Primary Cardiac Cause

• Heart failure with reduced ejection fraction is the dominant cause of Cheyne-Stokes breathing, particularly in males over 60 years with atrial fibrillation and recurrent pulmonary edema, with a correlation between the severity of cardiac dysfunction and the breathing pattern, as indicated by the American Academy of Sleep Medicine 9
• The severity of cardiac dysfunction directly correlates with the breathing pattern, with longer cycle lengths (73.9-85.7 seconds) occurring with left ventricular ejection fractions below 20%, and less severe dysfunction producing shorter cycles (49.1-58.9 seconds with LVEF >40%), according to the American Academy of Sleep Medicine 10
• A central apnea-hypopnea index >30/hour predicts poor survival in heart failure patients, as reported by the American Academy of Sleep Medicine 10

Neurological Causes

• Stroke is the second major cause of Cheyne-Stokes breathing, producing central periodic breathing through brainstem dysfunction and impaired respiratory control, as indicated by the American Heart Association 11
• Central periodic breathing (Cheyne-Stokes respirations) frequently complicates stroke and causes oxygen desaturation, with patients with decreased consciousness or brainstem involvement facing the highest risk, according to the American Heart Association 11

Distinguishing Features by Cycle Length

• Cycle length differentiates the underlying cause of Cheyne-Stokes breathing, with long cycle length (45-75 seconds) indicating classic heart failure with reduced ejection fraction, as reported by the American Academy of Sleep Medicine 9, 12
• Short cycle length (<45 seconds) suggests atrial fibrillation with heart failure, narcotics, pulmonary hypertension, renal failure, high altitude, or stroke, according to the American Academy of Sleep Medicine 9
• Very short cycle length (~26 seconds) indicates primary central sleep apnea without cardiac disease, as reported by the American Academy of Sleep Medicine 10

Clinical Diagnosis

• Formal diagnosis of Cheyne-Stokes respiration requires ≥3 consecutive central apneas/hypopneas with crescendo-decrescendo pattern, cycle length ≥40 seconds, and central AHI ≥5/hour over minimum 2 hours monitoring, as indicated by the American Academy of Sleep Medicine 12
• The American Academy of Sleep Medicine recommends that shorter cycles or absence of the classic crescendo-decrescendo pattern suggests alternative diagnoses like primary central sleep apnea or other causes 10

Diagnostic Monitoring Requirements for Cheyne‑Stokes Respiration

Polysomnographic Monitoring

• During polysomnography for suspected Cheyne‑Stokes respiration, continuous oxygen saturation monitoring should be performed to document desaturation episodes associated with central apneas/hypopneas. 13

• Respiratory effort assessment (e.g., rib‑cage and abdominal inductance plethysmography) must be included in polysomnography to distinguish central apneas (absent effort) from obstructive apneas (present effort); reliance solely on apnea‑bradycardia monitors or clinical screening tools is inadequate. 14

Therapeutic Considerations

• Supplemental oxygen alone is insufficient for treating Cheyne‑Stokes breathing; without concurrent ventilatory support, hypoventilation persists and may promote pulmonary hypertension. 14